Renal cell carcinoma is a common malignancy of uroepithelial region. It may metastasize even years after nephrectomy. Metastatic disease of thyroid gland is rare, the most common one is being renal cell carcinoma. Unlike the cases reported in the literature as tumor to tumor metastasis, our case had co-occurrence of multifocal renal cell carcinoma metastasis in the left thyroid lobe and thyroid papillary carcinoma in the right thyroid lobe, which were diagnosed at the same time. We presented this case due to its rare occurrence.
Introduction
Metastatic diseases of thyroid gland are rarely seen. Metastatic tumors constitute 2-3% of all thyroid malignancies. This incidence has been reported to be higher as 5-24% in autopsy series [1] . Thyroid metastasis of various type solid tumors such as malignant melanoma, renal cell carcinoma, breast cancer, lung cancer, head and neck tumors and hematological malignancies have been reported [2] . Although thyroid metastasis of renal cell carcinoma (RCC) has been reported, cases with co-occurrence of primary thyroid cancer and thyroid metastasis of RCC have mostly been reported as tumor to tumor metastasis in the literature [1] . Our case differently had concurrent thyroid metastasis of multifocal RCC and papillary thyroid carcinoma (PTC] and was presented due to its rare occurrence.
Case Report
A 65-year old male patient who had been diagnosed with RCC 2 years ago was referred to our clinic after detection of microcalcific and hypoechoic multiple nodules with hypoechoic halo in the right thyroid lobe on thyroid ultrasonography, the biggest one was being 35x22 mm in size. The patient had no symptoms and was euthyroid on admission. Anti-TPO and anti-TG were detected to be negative. Pathological examination of fine needle aspiration biopsy specimen obtained from the big nodule in the right lobe revealed oncocytic cell neoplasm and the patient underwent total thyroidectomy. Pathological examination demonstrated clear cell RCC metastasis in 3 focuses (2.5, 1.5 and 1.2 cm in size) in the right lobe and in one focus (5 cm in size) in the left lobe. In addition, there were two focuses (0.6 and 0.4 cm in size) of follicular and classical variant papillary microcarcinoma in the right lobe, which had no lymphovascular invasion and extra-thyroidal spread (Figure 1) The patient was scheduled for follow-up with TSH suppression. Neck ultrasonography performed in post-operative 3rd month visit revealed a 16x10 mm sized, microcalcific and spherical lymph node with no visible fatty hilum in the left cervical chain. Thyroglobulin (TG) level was measured as 0.75 ng/ ml and anti-TG was found to be negative. FNAB and TG wash-out were performed on the lymph node. Atypical lymphoid cells were detected in biopsy sample and TG wash-out result of the lymph node was 300 ng/ml. The patient underwent modified radical neck dissection. Among 36 lymph nodes extirpated, one was detected to show PTC metastasis. The patient was scheduled for postoperative radioactive iodine treatment.
Discussion
In clinical series, kidney, lung and skin [melanoma] cancers have been reported to be the most common tumors metastasizing to thyroid gland, while autopsy series reported breast, lung and skin [melanoma] originated tumors more commonly [2] [3] [4] .
In the literature, renal cell carcinoma was reported as the malignancy which most commonly (48.1%) metastasizes to thyroid [5] . Renal cell carcinoma is one of the most common cancers of urinary system, which is more common in men and in 6th and 7 th decades of life. The most common sites for RCC metastasis are lungs, bone, lymph nodes, liver, adrenal gland and brain, in order of decreasing frequency. Unlike other tumors, it may metastasize even years after nephrectomy [6] . FNAB is useful in the diagnosis of metastatic thyroid masses. Renal cell carcinoma metastasis, nodular hyperplasia and clear cell follicular adenomas appear very similar. Immunohistochemical staining is important in definitive differential diagnosis. CD10, vimentin, keratin and EMA [epithelial membrane antigen] immunoreactivity is especially detected in renal cell carcinoma metastases [2, 7] . Some renal tumors may cause false negative FDG-PET/CT results due to low glucose metabolism, small tumor size and intratumoral necrosis [8] . Our case also had negative PET/CT result but metastatic RCC. Some studies suggest that metastatic disease was more common in the patients with nodular goiter, adenoma, well-differentiated thyroid carcinoma and thyroiditis when compared to the individuals with normal thyroid tissue, which was thought to be due to abnormal blood supply causing decreased oxygen and iodine content [9] . As a result, immunohistochemical staining is important in the differential diagnosis of histological clear cell changes in the patients with the history of extra-thyroidal malignancy and it should not be overlooked that microenvironment of thyroid nodules provides an attractive media especially for renal cell carcinoma.
